Th17 cells could promote anti-tumor immune response by recruiting immune cells into the tumor microenvironment, inducing effector CD8+ T cells, or transforming to the Th1 phenotype and producing abundant IFN-γ (Guéry and Hugues, 2015). The gene discussed is IFNG; the disease is neoplasm.